GlassScriptPhysician profile
Harry H Park
NPI 1467430959
$10,239.54
in general payments reported to CMS, 2019-2025
33 companies · $2,431 in 2025
The $2,431 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,144 · 2020: $725 · 2021: $818 · 2022: $925 · 2023: $1,707 · 2024: $1,488 · 2025: $2,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,406 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,405.92 |
| Education | $220.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,064.89 | 2019-2025 | |
| Janssen Biotech, INC. | $1,054.46 | 2019-2025 | Tremfya, Stelara, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $953.66 | 2019-2025 | Xifaxan, Plenvu |
| Genzyme Corporation | $916.73 | 2022-2025 | |
| Celgene Corporation | $916.38 | 2022-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $876.68 | 2019-2025 | Entyvio |
| Madrigal Pharmaceuticals | $627.05 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $267.39 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $266.69 | 2022-2024 | Zeposia |
| Braintree Laboratories, INC. | $256.49 | 2019-2025 | Suflave, Sutab |
| Ferring Pharmaceuticals INC. | $120.46 | 2019 | |
| Shionogi INC | $109.54 | 2019 | |
| Intercept Pharmaceuticals, INC. | $87.40 | 2020-2024 | Ocaliva |
| Regeneron Healthcare Solutions, INC. | $78.00 | 2023-2025 | Dupixent |
| Novo Nordisk INC | $56.02 | 2025 | Wegovy |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $52.64 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $48.90 | 2019 | |
| Phathom Pharmaceuticals, INC. | $45.88 | 2024 | Voquezna |
| Daiichi Sankyo INC. | $45.37 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $45.28 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $44.47 | 2019 | |
| Lilly USA, LLC | $44.09 | 2019-2024 | Omvoh |
| Celltrion USA INC. | $43.98 | 2024-2025 | Vegzelma, Zymfentra |
| Biocon Biologics INC | $36.97 | 2025 | Yesintek, Hulio |
| Gilead Sciences, INC. | $33.50 | 2019 | |
| Orphalan INC | $27.52 | 2025 | Cuvrior |
| Ironwood Pharmaceuticals, INC | $25.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.83 | 2019 | |
| Echosens North America, INC. | $18.83 | 2024 | Fibroscan |
| Ipsen Biopharmaceuticals, INC | $18.66 | 2024 | Iqirvo |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Merck Sharp & Dohme LLC | $11.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $9.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.